Member: June 2015 - November 2019

Research interest
Plasmodium falciparum drug susceptibility analysed by in-vitro, ex-vivo assays, molecular biology

Title of PhD project
Reduced susceptibility to antimalarial drugs in Plasmodium spp

Supervisor
Prof. Dr. Frank P. Mockenhaupt

Bergmann C, van Loon W, Habarugira F, Tacoli C, Jäger JC, Savelsberg D, Nshimiyimana F, Rwamugema E, Mbarushimana D, Ndoli J, Sendegeya A, Bayingana C, Mockenhaupt FP (2021).
Increase in Kelch 13 Polymorphisms in Plasmodium falciparum, Southern Rwanda.
Emerging infectious diseases, 27(1), 294–296
doi:  10.3201/eid2701.203527

Wedam J, Tacoli C, Gai PP, Siegert K, Kulkarni SS, Rasalkar R, Boloor A, Jain A, Mahabala C, Baliga S, Shenoy D, Devi R, Gai P, Mockenhaupt FP (2018)
Molecular evidence for Plasmodium falciparum resistance to sulfadoxine-pyrimethamine but absence of K13 mutations in Mangaluru, southwestern India.
Am J Trop Med Hyg, 99:1508-1510
doi:10.4269/ajtmh.18-0549

Esu E, Tacoli C, Gai P, Berens-Riha N, Pritsch M, Loescher T, Meremikwu M. Prevalence of the Pfdhfr and Pfdhps mutations among asymptomatic pregnant women in Southeast Nigeria. (2018)
Parasitol Res. 117:801-7
doi: 10.1007/s00436-018-5754-5.

Tacoli C, Gai PP, Bayingana C, Sifft K, Geus D, Ndoli J, Sendegeya A, Gahutu JB, Mockenhaupt FP. (2016)
Artemisinin resistance-associated K13 polymorphisms of Plasmodium falciparum in Southern Rwanda, 2010-2015.
Am J Trop Med Hyg. 95(5):1090-1093.
doi: 10.4269/ajtmh.16-0483